.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
HealthQuad recently announced a strategic investment in LifeSigns, an innovative AI patient monitoring platform. Specifically, this funding will help the Chennai-based startup expand its international footprint. Consequently, healthcare providers can detect early signs of patient deterioration much faster. LifeSigns integrates medical-grade wearables with a predictive AI engine to improve safety.
For instance, it monitors heart rate, respiration, temperature, blood pressure, and oxygen saturation. Moreover, the system has already served over 325,000 patients across 50 facilities. This technology remarkably reduces code blue incidents by 90 per cent. Additionally, it lowers ICU readmissions by nearly 78 per cent. Clinicians can monitor data remotely through a cloud-based dashboard.
Therefore, clinicians can intervene earlier than ever before to save lives. Furthermore, the company plans to enter Southeast Asia and the GCC region soon. However, the exact investment amount remains undisclosed by the group. This model is globally relevant for the next wave of healthcare technology. Selective integrations will soon strengthen the existing technology stack for better hospital efficiency.
Q1: What specific vitals does the LifeSigns platform monitor?
The platform tracks heart rate, respiration, temperature, blood pressure, and oxygen saturation using medical-grade wearables.
Q2: How does the AI engine improve hospital safety?
It provides safety alerts by flagging early signs of clinical deterioration, which has reduced code blue incidents by 90 per cent.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
HealthQuad invests in LifeSigns, an AI-driven patient monitoring platform that reduces ICU readmissions by 78% and improves clinical outcomes globally....
5 months ago
Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today
A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
